bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Entrada Therapeutics Inc. logo

    Entrada Therapeutics Inc.

    TRDA | NASDAQ
    Chart Builder DCF Calculator
    $6.78
    +$0.14 (+2.11%)
    Sep 22, 2026, 11:07 AM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $257.77M
    Enterprise Value
    $83.31M
    Beta
    -0.25
    Average Volume
    428.91K
    Shares Outstanding (Diluted)
    42.22M
    Shares Change YoY
    2.14%
    Institutional Ownership
    60.90%
    Exchange
    NASDAQ
    ISIN
    US29384C1080

    Price Performance

    Price Change 1M
    -12.8%
    Price Change 3M
    -8.3%
    Price Change 6M
    -44.9%
    Price Change YTD
    -33.9%
    Price Change 1Y
    25.8%
    Price Change 3Y
    -54.0%
    Price Change 5Y
    -72.3%
    1M CAGR (ann.)
    -3.4%
    1Y CAGR (ann.)
    19.6%
    5Y CAGR (ann.)
    N/A
    All-Time CAGR
    -23.0%

    Valuation

    PE Ratio
    -1.67
    Forward PE
    N/A
    PEG Ratio
    0.02
    Forward PEG
    0.12
    PS Ratio
    55.01
    Forward PS
    12.90
    PB Ratio
    1.10
    P/FCF Ratio
    -1.87
    P/Adj. FCF Ratio
    -1.59
    P/OCF Ratio
    -2.08
    EV/Sales
    17.78
    EV/EBIT
    -0.51
    EV/EBITDA
    -0.51
    EV/FCF
    -0.61
    Earnings Yield
    -59.8%
    FCF Yield
    -53.4%
    Adj. FCF Yield
    -62.7%

    Financial Health

    Net Cash
    $223.01M
    Total Debt
    $48.54M
    Cash & Short-Term Investments
    $223.01M
    Total Assets
    $298.88M
    Current Ratio
    10.89
    Quick Ratio
    10.89
    Debt / Equity Ratio
    0.21
    Debt / EBITDA
    -0.29
    Debt / FCF
    -0.35
    OCF / Debt
    -2.84
    Interest Coverage
    0.00
    Altman Z-Score
    -0.26
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    -754.7%
    Operating Profit Margin
    -3767.1%
    EBITDA Margin
    -3518.3%
    Net Profit Margin
    -3537.7%
    FCF Margin
    -2935.9%
    Adj. FCF Margin
    -3450.4%
    SBC / Revenue
    413.3%
    SBC Impact (per share)
    -17.5%

    Returns

    Return on Assets
    -55.5%
    Return on Equity
    -57.6%
    Return on Invested Capital
    -62.6%
    Return on Capital Employed
    -63.6%
    Return on Tangible Assets
    -55.5%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -52.4%
    Revenue CAGR 5Y
    6.2%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    -372.6%
    EPS CAGR 5Y
    -10.7%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -63.2%
    FCF CAGR 5Y
    -71.0%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    6
    EPS Growth Next 3Y
    10.6%
    Revenue Growth Next 3Y
    148.4%
    Earnings Date
    Nov 4, 2026
    EPS Estimate (next Q)
    -$0.98
    EPS Growth Est (next Q)
    -7.5%
    Revenue Est (next Q)
    $2.13M
    Revenue Growth Est (next Q)
    32.2%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $14
    Price Target Upside
    110.8%

    Cash Flow

    Operating Cash Flow
    $-137.9M
    Free Cash Flow
    $-137.58M
    Adj. Free Cash Flow
    $-161.69M
    FCF Per Share
    -$3.18
    OCF Per Share
    -$3.19
    OCF/S Ratio
    -2874.0%

    Income Statement

    Revenue
    $4.69M
    Gross Profit
    $-35.37M
    Operating Income
    $-176.53M
    EBITDA
    $-164.87M
    Net Income
    $-165.78M
    EPS (Diluted)
    -$3.97
    Revenue / Employee
    $30.83K
    Profit / Employee
    $-1.09M
    Employees
    152

    © 2026 bestshares.com. All rights reserved.